×

Inspire Medical Systems Share Holder Equity 2017-2024 | INSP

Inspire Medical Systems share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Inspire Medical Systems Annual Share Holder Equity
(Millions of US $)
2024 $690
2023 $573
2022 $496
2021 $229
2020 $230
2019 $140
2018 $164
2017 $1
2016 $0
Inspire Medical Systems Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $690
2024-09-30 $697
2024-06-30 $638
2024-03-31 $589
2023-12-31 $573
2023-09-30 $544
2023-06-30 $529
2023-03-31 $505
2022-12-31 $496
2022-09-30 $470
2022-06-30 $227
2022-03-31 $225
2021-12-31 $229
2021-09-30 $220
2021-06-30 $220
2021-03-31 $223
2020-12-31 $230
2020-09-30 $229
2020-06-30 $234
2020-03-31 $127
2019-12-31 $140
2019-09-30 $146
2019-06-30 $152
2019-03-31 $157
2018-12-31 $164
2018-09-30 $98
2018-06-30 $103
2018-03-31 $-5
2017-12-31 $1
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.470B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00